von Glasenapp V, Almeida A, Chang D, Gasic I, Winssinger N, Gotta M
Nat Commun. 2025; 16(1):1599.
PMID: 39971898
PMC: 11840123.
DOI: 10.1038/s41467-025-56746-5.
Baek H, Das D, Chen S, Li H, Arur S
Cell Rep. 2025; 44(1):115157.
PMID: 39792558
PMC: 11874628.
DOI: 10.1016/j.celrep.2024.115157.
Guelle M, Emond-Fraser V, Archambault V
Cell Div. 2024; 19(1):36.
PMID: 39732709
PMC: 11682627.
DOI: 10.1186/s13008-024-00141-x.
Bonneil E, Larouche M, Emond-Fraser V, Kubiniok P, Pascariu C, Thibault P
Methods Mol Biol. 2024; 2874:167-182.
PMID: 39614055
DOI: 10.1007/978-1-0716-4236-8_14.
Najera P, Dratler O, Mai A, Elizarraras M, Vanchinathan R, Gonzales C
G3 (Bethesda). 2024; 15(1.
PMID: 39566185
PMC: 11708218.
DOI: 10.1093/g3journal/jkae273.
RNA Sequencing Reveals That the Genes Related to Cell Cycle and Glycolysis Play an Essential Role in IL-27-Induced Keratinocyte Hyperproliferation.
Wu Z, Wang R, Liu Y, Yang B, Wang H
J Inflamm Res. 2024; 17:8165-8180.
PMID: 39525318
PMC: 11545624.
DOI: 10.2147/JIR.S481835.
PLK2-mediated phosphorylation of SQSTM1 S349 promotes aggregation of polyubiquitinated proteins upon proteasomal dysfunction.
Chen Y, Lin X, Ruan Z, Li M, Yi X, Zhang X
Autophagy. 2024; 20(10):2221-2237.
PMID: 39316746
PMC: 11423667.
DOI: 10.1080/15548627.2024.2361574.
CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer.
Zhong C, Jiang W, Yao Y, Li Z, Li Y, Wang S
Nat Commun. 2024; 15(1):5502.
PMID: 38951519
PMC: 11217446.
DOI: 10.1038/s41467-024-49673-4.
Identification of a novel prognostic signature based on vitamin metabolism clustering-related genes in lung adenocarcinoma.
Chen Y, Jiang Y, Li X, Huang H, Zhou Y, Zhang C
Transl Lung Cancer Res. 2024; 13(5):1084-1100.
PMID: 38854940
PMC: 11157371.
DOI: 10.21037/tlcr-24-245.
Inhibition of Aberrantly Overexpressed Polo-like Kinase 4 Is a Potential Effective Treatment for DNA Damage Repair-Deficient Uterine Leiomyosarcoma.
Lee H, Chow K, Wong H, Chong T, Wong A, Cheng G
Clin Cancer Res. 2024; 30(17):3904-3918.
PMID: 38848043
PMC: 11369621.
DOI: 10.1158/1078-0432.CCR-23-3720.
Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutations.
Fukuda K, Takeuchi S, Arai S, Nanjo S, Sato S, Kotani H
Cell Rep Med. 2024; 5(6):101578.
PMID: 38776912
PMC: 11228449.
DOI: 10.1016/j.xcrm.2024.101578.
PLK1 phosphorylation of ZW10 guides accurate chromosome segregation in mitosis.
Bellah S, Xiong F, Dou Z, Yang F, Liu X, Yao X
J Mol Cell Biol. 2024; 16(2).
PMID: 38402459
PMC: 11328731.
DOI: 10.1093/jmcb/mjae008.
Dissecting the Multiple Functions of the Polo-Like Kinase 1 in the C. elegans Zygote.
Velez-Aguilera G, Ossareh-Nazari B, Pintard L
Methods Mol Biol. 2024; 2740:63-88.
PMID: 38393469
DOI: 10.1007/978-1-0716-3557-5_4.
The yin and yang of chromosomal instability in prostate cancer.
Carceles-Cordon M, Orme J, Domingo-Domenech J, Rodriguez-Bravo V
Nat Rev Urol. 2024; 21(6):357-372.
PMID: 38307951
PMC: 11156566.
DOI: 10.1038/s41585-023-00845-9.
Promising antimalarial hits from phenotypic screens: a review of recently-described multi-stage actives and their modes of action.
Luo A, Giannangelo C, Siddiqui G, Creek D
Front Cell Infect Microbiol. 2024; 13:1308193.
PMID: 38162576
PMC: 10757594.
DOI: 10.3389/fcimb.2023.1308193.
Effects of µ-Conotoxin GIIIB on the cellular activity of mouse skeletal musculoblast: combined transcriptome and proteome analysis.
Wu H, He P, Jia R
Proteome Sci. 2023; 21(1):17.
PMID: 37828502
PMC: 10568904.
DOI: 10.1186/s12953-023-00221-w.
Design, synthesis, and biological evaluation of novel pyrimidin-2-amine derivatives as potent PLK4 inhibitors.
Xue Y, Mu S, Sun P, Sun Y, Liu N, Sun Y
RSC Med Chem. 2023; 14(9):1787-1802.
PMID: 37731702
PMC: 10507801.
DOI: 10.1039/d3md00267e.
PLK1 inhibition dampens NLRP3 inflammasome-elicited response in inflammatory disease models.
Baldrighi M, Doreth C, Li Y, Zhao X, Warner E, Chenoweth H
J Clin Invest. 2023; 133(21).
PMID: 37698938
PMC: 10617773.
DOI: 10.1172/JCI162129.
Genetic enhancers of partial PLK1 inhibition reveal hypersensitivity to kinetochore perturbations.
Normandin K, Coulombe-Huntington J, St-Denis C, Bernard A, Bourouh M, Bertomeu T
PLoS Genet. 2023; 19(8):e1010903.
PMID: 37639469
PMC: 10491399.
DOI: 10.1371/journal.pgen.1010903.
Structural Basis for Variations in Polo-like Kinase 1 Conformation and Intracellular Stability Induced by ATP-Competitive and Novel Noncompetitive Abbapolin Inhibitors.
Chapagai D, Merhej G, McInnes C, Wyatt M
ACS Chem Biol. 2023; 18(7):1642-1652.
PMID: 37433100
PMC: 11295584.
DOI: 10.1021/acschembio.3c00269.